Scribd Logo
Upload

Welcome to Scribd!

  • Global Cancer Vaccines Pipeline Analysis

    Uploaded by

    pnspharma
    5 views2 pages
    "Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. With the approval of the expensive prostate cancer vaccine, Provenge by Dendreon, the field of cancer vaccines has received an unprecedented boost. Therapeutic cancer vaccines and Prophylactic cancer vaccines are the two broad segments into which the cancer vaccines market is categorized. North America has the largest share of the overall vaccines and specifically cancer vaccines market. This is followed by Europe and Asia. North America and Europe are expected to grow at a steady pace in the years to come. However, India and China are expected to see a boost in demand over the next 10 years, owing to their ageing populations and the prevalence of various infectious diseases. “Global Cancer Vaccines Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various vaccines being developed for the treatment of multiple cancers. Research report covers all the ongoing vaccines being developed in various development phases. Each vaccine profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight for each vaccine profile in development phase enables the reader to identify and understand the Cell Therapy associated with the various diseases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the cancer vaccine market based upon development process. Following parameters for each vaccine profile in development phase are covered in “Global Cancer Vaccines Pipeline Analysis” research report: • Drug Profile Overview • Alternate Names for Drug • Active Indication • Phase of Development • Mechanism of Action • Brand Name • Patent Information • Orphan Designation by Indication, Country & Organisation • Country for Clinical Trial • Owner / Originator/ Licensee/Collaborator • Administrative Route • Drug Class • ATC Codes Breakup of Cancer Vaccines by Development Phase: • Research: 9 • Preclinical: 75 • Phase-I: 42 • Phase-I/II: 32 • Phase-II: 43 • Phase-II/III: 6 • Phase-III: 19 • Preregistration: 2 • Marketed: 12 "

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    "Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. With the approval of the expensive prostate cancer vaccine, Provenge by Dendreon, the field of cancer vaccines has received an unprecedented boost. Therapeutic cancer vaccines and Prophylactic cancer vaccines are the two broad segments into which the cancer vaccines market is categorized. North America has the largest share of the overall vaccines and specifically cancer vaccines market. This is followed by Europe and Asia. North America and Europe are expected to grow at a steady pace in the years to come. However, India and China are expected to see a boost in demand over the next 10 years, owing to their ageing populations and the prevalence of various infectious diseases. “Global Cancer Vaccines Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various vaccines being developed for the treatment of multiple cancers. Research report covers all the ongoing vaccines being developed in various development phases. Each vaccine profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight for each vaccine profile in development phase enables the reader to identify and understand the Cell Therapy associated with the various diseases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the cancer vaccine market based upon development process. Following parameters for each vaccine profile in development phase are covered in “Global Cancer Vaccines Pipeline Analysis” research report: • Drug Profile Overview • Alternate Names for Drug • Active Indication • Phase of Development • Mechanism of Action • Brand Name • Patent Information • Orphan Designation by Indication, Country & Organisation • Country for Clinical Trial • Owner / Originator/ Licensee/Collaborator • Administrative Route • Drug Class • ATC Codes Breakup of Cancer Vaccines by Development Phase: • Research: 9 • Preclinical: 75 • Phase-I: 42 • Phase-I/II: 32 • Phase-II: 43 • Phase-II/III: 6 • Phase-III: 19 • Preregistration: 2 • Marketed: 12 "

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    5 views2 pages

    Global Cancer Vaccines Pipeline Analysis

    Uploaded by

    pnspharma
    "Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. With the approval of the expensive prostate cancer vaccine, Provenge by Dendreon, the field of cancer vaccines has received an unprecedented boost. Therapeutic cancer vaccines and Prophylactic cancer vaccines are the two broad segments into which the cancer vaccines market is categorized. North America has the largest share of the overall vaccines and specifically cancer vaccines market. This is followed by Europe and Asia. North America and Europe are expected to grow at a steady pace in the years to come. However, India and China are expected to see a boost in demand over the next 10 years, owing to their ageing populations and the prevalence of various infectious diseases. “Global Cancer Vaccines Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various vaccines being developed for the treatment of multiple cancers. Research report covers all the ongoing vaccines being developed in various development phases. Each vaccine profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight for each vaccine profile in development phase enables the reader to identify and understand the Cell Therapy associated with the various diseases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the cancer vaccine market based upon development process. Following parameters for each vaccine profile in development phase are covered in “Global Cancer Vaccines Pipeline Analysis” research report: • Drug Profile Overview • Alternate Names for Drug • Active Indication • Phase of Development • Mechanism of Action • Brand Name • Patent Information • Orphan Designation by Indication, Country & Organisation • Country for Clinical Trial • Owner / Originator/ Licensee/Collaborator • Administrative Route • Drug Class • ATC Codes Breakup of Cancer Vaccines by Development Phase: • Research: 9 • Preclinical: 75 • Phase-I: 42 • Phase-I/II: 32 • Phase-II: 43 • Phase-II/III: 6 • Phase-III: 19 • Preregistration: 2 • Marketed: 12 "

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 2

    Global Cancer Vaccines Pipeline Analysis

    Cancer vaccines are a viable option for treating many types of cancers which in the present
    day do not have effective treatments. With the approval of the expensive prostate cancer
    vaccine, Provenge by Dendreon, the field of cancer vaccines has received an unprecedented
    boost. Therapeutic cancer vaccines and Prophylactic cancer vaccines are the two broad
    segments into which the cancer vaccines market is categorized. North America has the largest
    share of the overall vaccines and specifically cancer vaccines market. This is followed by
    Europe and Asia. North America and Europe are expected to grow at a steady pace in the
    years to come. However, India and China are expected to see a boost in demand over the
    next 10 years, owing to their ageing populations and the prevalence of various infectious
    diseases.
    Global Cancer Vaccines Pipeline Analysis by PNS Pharma gives comprehensive insight on
    the various vaccines being developed for the treatment of multiple cancers. Research report
    covers all the ongoing vaccines being developed in various development phases. This report
    enables pharmaceutical companies, collaborators and other associated stake holders to
    identify and analyze the available investment opportunity in the cancer vaccine market based
    upon development process.
    For Report Sample Contact: rajesh@pnspharma.com
    Following parameters for each vaccine profile in development phase are covered in Global
    Cancer Vaccines Pipeline Analysis research report:
    Drug Profile Overview
    Alternate Names for Drug
    Active Indication
    Phase of Development
    Mechanism of Action
    Brand Name
    Patent Information
    Orphan Designation by Indication, Country & Organisation
    Country for Clinical Trial
    Owner / Originator/ Licensee/Collaborator
    Administrative Route Drug Class
    ATC Codes
    Breakup of Cancer Vaccines by Development Phase:
    Research: 9
    Preclinical: 75
    Phase-I: 42
    Phase-I/II: 32
    Phase-II: 43
    Phase-II/III: 6
    Phase-III: 19
    Preregistration: 2
    Marketed: 12
    For Report Sample Contact: rajesh@pnspharma.com
    Each Drug Profile has Tables Representing Following Information:
    * Alternate names
    * Originator & Owner
    * Collaborator
    * Technology Provider
    * Licensee
    * Development phase
    * Active Development - Indications
    * Class * Mechanism of Action
    * ATC code
    * Allocated Brand Name & Orphan Designation

    You might also like